ARTICLE | Company News
Jazz Pharmaceuticals sales and marketing update
February 24, 2014 8:00 AM UTC
Jazz launched Versacloz clozapine in the U.S. to treat severely ill treatment-resistant schizophrenia patients or those at risk of recurrent suicidal behavior with schizophrenia or schizoaffective di...